Mitochondrial protein import requires cooperation of the machineries called translocators in the outer and inner mitochondrial membranes. Here we analyze the interactions of Tom22, a multifunctional subunit of the outer membrane translocator TOM40 complex, with other translocator subunits such as Tom20, Tom40, and Tim50 and with substrate precursor proteins at a spatial resolution of the amino acid residue by in vivo and in organello site-specific photocross-linking. Changes in cross-linking patterns caused by excess substrate precursor proteins or presequence peptides indicate how the cytosolic receptor domain of Tom22 accepts substrate proteins and how the intermembrane space domain of Tom22 transfers them to Tim50 of the inner-membrane translocator.
M
itochondria, a powerhouse of eukaryotic cells, consist of 1,000-1,500 different proteins that are mainly synthesized in the cytosol and placed in four subcompartments, the outer and inner membranes and the aqueous intermembrane space (IMS) and matrix (1) (2) (3) . Import and subsequent intramitochondrial sorting of mitochondrial proteins are mediated by the mitochondrial membrane-protein complexes called translocators. The translocator complexes in the outer and inner membranes are not tightly linked with each other, yet dynamically cooperate to achieve protein delivery to each mitochondrial subcompartment. Besides, translocator complexes are dynamic entities on their own, and alter their subunit-subunit interactions to work in demand for imported client proteins with different destinations (4) (5) (6) . To understand the mechanism of protein transport by the mitochondrial import/sorting systems, it is essential to monitor and analyze dynamic interactions among the constituents of the systems, and in organello and in vivo are techniques providing sufficiently high spatial resolution.
Most matrix proteins and some inner-membrane proteins are synthesized as precursor proteins with an amino-terminal cleavable presequence, which contains a mitochondrial targeting signal. Presequences generally have potentials to form a positively charged amphiphilic helical structure. The outer membrane translocator, the TOM40 complex, functions as an entry gate for most mitochondrial proteins. The yeast TOM40 complex is composed of the core complex consisting of Tom40, Tom22, Tom5, Tom6, and Tom7, and peripheral receptor subunits, Tom20 and Tom70. Tom20 is a general import receptor and anchored to the outer membrane by its N-terminal transmembrane (TM) segment. Tom22 spans the outer membrane by its central TM segment, with its N-terminal and C-terminal domains exposed to the cytosol and IMS, respectively (7, 8) . The cytosolic domains of Tom20 and Tom22 cooperate to form a presequence receptor site called the cis site to recognize mitochondrial targeting signals (9) (10) (11) (12) . After recognition by the receptor subunits of the TOM40 complex, presequence-containing precursor proteins move across the outer membrane through the β-barrel Tom40 channel (13) (14) (15) , which is stabilized by Tom22 (16). Then the presequence is recognized by another receptor site of the TOM40 complex on the IMS side called the trans site, which consists of the IMS-facing region of Tom40, Tom22, and Tom7 (17) (18) (19) (20) (21) . The presequence is subsequently forwarded to Tim50, an essential subunit of the inner-membrane translocator, the TIM23 complex (22) (23) (24) . The TIM23 complex allows presequence transfer to the matrix through the α-helical Tim23 channel utilizing the energy of the membrane potential across the inner membrane (ΔΨ) and ATP hydrolysis by the import motor, mitochondrial Hsp70 in the matrix.
In the present study, we attempt to make protein-interaction mapping of a multifunctional subunit of the TOM40 complex, Tom22, which consists of the three distinct domains that play different roles in mitochondrial protein transport in the cytosol, outer membrane, and IMS. Because no high-resolution structural information is available for Tom22, we adopted in vivo and in organello site-specific photocross-linking to assess protein-protein interactions of Tom22 at its work. Briefly, the gene for Tom22 containing an amber codon for a desired position is introduced into yeast cells that contains an orthogonal pair of amber suppressor tRNA and its cognate aminoacyl-tRNA synthetase specific for DL-2-amino-3-(p-benzoylphenyl)pentanoic acid (BPA) (25) . Addition of BPA into culture medium allows incorporation of BPA into Tom22 at the position specified by the amber codon. Subsequent UV irradiation of yeast cells or isolated mitochondria result in photocross-linking of BPA in Tom22 with nearby proteins. Cross-linked partner proteins can be identified by immunoblotting with antibodies against possible candidates or molecularweight shift of the cross-linked products by epitope tagging of the possible candidates.
Results and Discussion
The Cytosol Domain of Tom22 Interacts with Tom20 in a PresequenceDependent Manner. Yeast Tom22 is predicted to consist of three domains: the N-terminal cytosolic domain (residues 1-97), central TM domain (residues 98-119), and C-terminal IMS domain (residues 120-152). A modified TOM22 gene with an amber codon in a specific position was placed under the control of the galactose-inducible GAL1 promoter and was introduced into yeast cells that contain an orthogonal pair of amber suppressor tRNA and its cognate aminoacyl-tRNA synthetase specific for BPA. When BPA was added to the culture medium, Tom22 containing BPA at the amber-specified position in addition to the Tom22 derivative truncated at the amber-specified position was produced (Fig. S1A ). Because Tom22 is essential for yeast cell growth under most conditions (7, 8, 15) , we confirmed that Tom22 with BPA could take over the essential functions of wildtype (WT) Tom22 (Fig. S1B ) and be assembled into the TOM40 complex (Fig. S2) when expression of endogenous Tom22 was shut off.
We then overexpressed Tom22 containing BPA in the N-terminal cytosolic domain from the GAL1 promoter in yeast cells in the presence of endogenous WT Tom22, and UV irradiated the cells. Affinity purification of the cross-linked products with the C-terminal His 10 tag and subsequent immunoblotting revealed that BPA at residue 48 of Tom22 was cross-linked to Tom20 (Fig. 1A) . When the position of BPA was varied, cross-linking to Tom20 was the most prominent around residues 44-52, a region rich in acidic residues (Fig. 1C) . Conversely, when we introduced BPA at residue 98 in the cytosolic receptor domain of Tom20, UV irradiation resulted in cross-linking to Tom22 and Tom40 (Fig. 1B) . When the position of BPA was varied, cross-linking to Tom22 was the most prominent around helix α1 of Tom20, which constitutes a part of the hydrophobic groove as the presequence binding site in homologous rat Tom20 (9) (Fig. 1 D and E) .
Next, we asked if the Tom20-interacting acidic region of Tom22 is involved in the presequence recognition, as well (12) . We isolated mitochondria containing Tom22 with BPA at residue 48 or 60 and incubated them with a radiolabeled model precursor protein pSu9-DHFR, a fusion protein between the 69-residue presequence of the precursor to subunit nine of Neurospora crassa F o -ATPase and mouse dihydrofolate reductase (DHFR), in the absence of ΔΨ. A previous study showed that, upon incubation with mitochondria lacking ΔΨ, pSu9-DHFR is accumulated at the level of the TOM40 complex, forming two distinct intermediates at stage A (at low temperature) or at stage B (at elevated temperature) (20) . At stage A, a positively charged N-terminal segment of the long presequence binds to the trans site through electrostatic interactions without unfolding of the DHFR part whereas at stage B the DHFR part is unfolded and trapped by the inner wall of the Tom40 channel mainly through hydrophobic interactions. Both at stages A and B, BPA at residue 48 (in the acidic Tom20-interacting region), but not at residue 60 (outside the acidic region), of Tom22 was cross-linked to pSu9-DHFR ( Fig. 2A) . Therefore while the C-terminal half of the pSu9 presequence is in contact with the cytosolic domain of Tom22 as well as Tom20 at stage A (26), the unfolded DHFR part is in contact with the Tom22 cytosol domain at stage B, suggesting the possible chaperoning role of the Tom22 cytosol domain.
A next question is if the cytosolic domains of Tom20 and Tom22 dissociate from each other to accommodate the presequence. We thus overexpressed Tom22 with BPA at position 48 in vivo with or without simultaneous overexpression of pb 2 ð167ÞΔ19-DHFR, a fusion protein between the matrix-targeting N-terminal 167 residues of yeast cytochrome b 2 precursor with 19-residue deletion of the sorting signal and DHFR, from the GAL1 promoter. We observed accumulation of the precursor form of Mdj1p, a matrixlocalized protein, upon overexpression of pb 2 ð167ÞΔ19-DHFR, suggesting that pb 2 ð167ÞΔ19-DHFR saturates the protein import machineries in mitochondria (Fig. S3A) . The amounts of the crosslinked products of Tom22 with Tom20 now decreased upon overexpression of pb 2 ð167ÞΔ19-DHFR (Fig. 2B) . We isolated mitochondria containing Tom22 with BPA at position 48 or 75, and after dissipation of ΔΨ, we UV-irradiated them in the absence or presence of increasing amounts of residues 1-22 of the rat aldehyde dehydrogenase presequence (pALDH), which is recognized by the import receptor Tom20 (9) . The amounts of the cross-linked products of Tom22 with Tom20 decreased for BPA at position 48 (in the acidic region), but not for BPA at position 75 (outside the acidic region), in the presence of pALDH (Fig. 2C) , although like Tom22, cross-linking of Tom20 to cis-site bound substrate peptides was hardly observed (21, 26) . These results indicate that the acidic region of Tom22 competes with the presequence for the interaction with Tom20, fitting for the model that Tom20 and Tom22 recognize the hydrophobic side and the positively charged side, respectively, of the amphiphilic helix of the presequence simultaneously (12, 27) .
The TM Helix of Tom22 Interacts with Two Molecules of Tom40. We then probed interactions of the TM segment of Tom22 with other subunits of the TOM40 complex in vivo. BPA at residue 107 in the TM segment of Tom22 was found to be cross-linked to Tom40 (Fig. 3A) . When we changed the position of BPA at every residue throughout the TM segment (residues 98-119), Tom40 was crosslinked to BPA at residues 100, 101, 103, 105, 107, 108, 112, 114, 115, 116, 118, and 119 of Tom22 (Fig. 3B , Left) whereas BPA in the cytosol or IMS domain of Tom22 was not cross-linked to Tom40. This is in contrast to Tom20, which was cross-linked to Tom40 mainly through the helices α1 and α2 in the cytosol domain ( Fig. 1A and Fig. 3C ).
Mapping of Tom40-interacting residues on the helical wheel plot of the Tom22 TM segment showed that they are segregated into two sides of the TM helix (Fig. 3B , Right). Does this mean that the TM helix of one Tom22 molecule simultaneously interacts with two molecules of Tom40 or that Tom22 consists of two populations, each of which is in contact with a single Tom40 molecule? To address this question we introduced two amber codons simultaneously into the TOM22 gene. For example, the mutant TOM22 gene with amber codons for residues 103 and 116 allows expression of full length Tom22 with double BPA at both residues 103 and 116 as well as those with a single BPA at either residue 103 or 116. After UV irradiation, those BPA containing Tom22 species generated cross-linked products with not only one Tom40 molecule (85 kDa) but also two Tom40 molecules at the same time (160 kDa), indicating that BPA at residues 103 and 116 are simultaneously in contact with Tom40 (Fig. 3D ). On the other hand, BPA at residues 103 and 118 or BPA at residues 101 and 116 generated only single-Tom40 containing cross-linked products, but , and TSY1/pTS1-103,116) with overexpressed Tom22 containing BPA at residues 103∕118, residues 101∕116, and residues 103∕116 were UV-irradiated and analyzed as in Fig. 1A . (E) Mitochondria containing Tom22 with BPA at residue 118 were purified and subjected to in vitro binding of indicated amounts of pALDH peptides in the absence of ΔΨ as in Fig. 2C . After UV-irradiation, proteins were analyzed as in Fig. 1A . The bands with an asterisk is overlapped by the one from the cross-linked product with Tim50 (see Fig. 4C ). The 22, Tom22; 22-40, Tom22 cross-linked with Tom40.
not double-Tom40 containing cross-linked products (Fig. 3D) . Therefore the TM helix of Tom22 interacts with two Tom40 molecules through the two distinct regions containing residues 103 and 118 and residues 101 and 116, which will contribute to stabilization of the Tom40 oligomeric structure. This is consistent with the topological arrangement of three Tom22 and three Tom40 molecules in the TOM40 complex determined by cryo-EM analyses (15) . Does this topological arrangement of Tom40 and Tom22 respond to translocating precursor proteins? We isolated mitochondria containing Tom22 with BPA at position 118 or 105, and UV-irradiated them in the absence of ΔΨ, but in the presence of increasing amounts of the presequence peptide pALDH (Fig. 3E and Fig. S3B ). The amounts of the cross-linked products between Tom22 and Tom40 were not affected by pALDH, suggesting that the Tom22-Tom40 interactions do not change upon translocation of substrate presequences.
Interaction of the IMS Domains of Tom22 and Tim50 Responds to the Presequence. Next we introduced BPA in the IMS domain (residues 120-152) of Tom22 in vivo and UV-irradiated. BPA at residue 132 in the Tom22 IMS domain was found to be crosslinked to Tim50 (Fig. 4A, Left) . We detected similar cross-linking between FLAG-tagged Tim50 and nontagged Tom22, ruling out the possibility that the Tim50-Tom22 cross-linking arose from artifacts due to the His 10 tag (Fig. S3C ). When we changed the position of BPA at every residue throughout the IMS domain except for the very C-terminal 6 residues (residues 120-146), Tim50 was clearly cross-linked to BPA at residues 118, 121, 132, 134, 136, 140, and 145 of Tom22 (Fig. 4B) .
Tim50 is anchored to the inner membrane by its TM segment near the N terminus, exposing a large C-terminal domain to the IMS, which could interact with mitochondrial presequences (22) . We thus asked if Tom22-Tim50 interactions would be affected by the translocating precursor proteins or presequence peptides. When mitochondrial precursor protein pb 2 ð167ÞΔ19-DHFR was overexpressed, the cross-linking between BPA at residue 136 of Tom22 and Tim50 decreased in vivo (Fig. 4C) . When mitochondria containing BPA at residue 136 were isolated and UV-irradiated in the absence of ΔΨ, the cross-linking between Tom22 and Tim50 also decreased with increasing amounts of pALDH (Fig. 4D) . Therefore the IMS domains of Tom22 and Tim50 likely dissociate from each other upon precursor protein transfer from the TOM40 complex to the TIM23 complex.
We then isolated mitochondria with Tom22 containing BPA at residue 136 or 143 in the IMS domain and incubated them with radiolabeled pSu9-DHFR in the absence of ΔΨ. At both stages A (4°C) and stage B (30°C), the interactions between the presequence of the translocation intermediate of pSu9-DHFR and the IMS domain (residues 136 and 143) of Tom22 were abolished by high concentration of KCl (Fig. 4E) . A previous study showed that cross-linking of the presequence of the stage B intermediate of pSu9-DHFR to Tim50 was observed only after wash of mitochondria with 150 mM KCl, but not with 15 mM KCl (26) . Therefore, whereas the presequence interacts with Tom22 in the IMS primarily through electrostatic interactions, the interactions between the presequence and Tim50 are hydrophobic rather than electrostatic. We now examined if the interactions between the IMS domains of Tom22 and Tim50 are sensitive to KCl concentrations. When we increased the salt concentration from 15 to 150 mM, the cross-link between the Tom22 IMS domain and Tim50 increased (Fig. 4F) , suggesting that the interactions between Tom22 and Tim50 in the IMS are, like those between the presequence and Tim50, mainly hydrophobic rather than electrostatic. Therefore the presequence and the IMS domain of Tom22 likely compete with each other to bind to Tim50 by hydrophobic interactions. 
Conclusion
In the present study, we employed in vivo site-specific incorporation of BPA into Tom22, a multifunctional subunit of the TOM40 complex, to analyze its interactions with the subunits of the TOM40 and TIM23 complexes and substrate precursor proteins by photocross-linking. We assessed possible changes in interactions of Tom22 with other translocator subunits in response to substrate translocating proteins by overexpressing mitochondrial precursor proteins in vivo or adding chemical amounts of mitochondrial presequence peptides in vitro to partly saturate the import machineries of the TOM40 complex. By doing so, we found the followings. First, the clamp of the cytosolic receptor domains of Tom22 and Tom20 opens to accept presequences for targeting signal recognition. Second, whereas the cytosolic domain of Tom20 interacts with Tom40, the TM helix of Tom22 tethers two Tom40 molecules, yet those interactions are not affected by substrate presequences. Third, dynamic interactions between the IMS domains of Tom22 and Tim50 promote transfer of the mitochondrial presequence from Tom22 to Tim50, suggesting the following scenario. Whereas the transient interaction between Tim50 and Tom22 brings the TIM23 complex closer to the TOM40 complex, the presequence of the incoming precursor protein binds to the IMS domain of Tom22 when the Tom22 IMS domain is not occupied with Tim50. Then binding of Tim50 to Tom22 clears the presequence from Tom22, and Tim50 receives the presequence, thereby facilitating efficient presequence transfer from the TOM40 complex to the downstream TIM23 complex. The present study demonstrates that in vivo site-specific photocross-linking can serve as a useful tool to provide interaction-map snapshots for membrane-protein complexes at work.
Materials and Methods
Plasmids and Strains. Constructions of yeast strains and plasmids (Tables S1-S4) are described in SI Materials and Methods.
Growth conditions. Cells were grown in YPD (1% yeast extract, 2% polypeptone, and 2% glucose), SD (0.67% yeast nitrogen base without amino acids and 2% glucose), SCD (0.67% yeast nitrogen base without amino acids, 0.5% casamino acid, and 2% glucose), SGal (0.67% yeast nitrogen base without amino acids and 2% galactose), or SCGal (0.67% yeast nitrogen base without amino acids, 0.5% casamino acid, and 2% galactose) media with appropriate supplements.
In Vivo and in Organello Photocross-Linking. The plasmids for in vivo BPA crosslinking were provided by P.G. Schultz (The Genomics Institute of the Novartis Research Foundation). Site-specific photocross-linking in vivo and in organello was performed as described previously (6, 20, 26) and in SI Materials and Methods. Preparation of pALDH is described in SI Materials and Methods. Table S1 . TOM22FLAG, a yeast haploid strain for expression of C-terminally FLAG-tagged Tom22 instead of corresponding WT Tom22 was constructed as follows. A DNA fragment for the triple-FLAG epitope tag and that containing the Candida glabrata HIS3 (CgHIS3) marker were amplified from pTYE247 by PCR using primers Tom22-FLAG-F (5′-ATT GGC CCA AGG TGA AAA AGA TGC TGC AGC AAC AGC CAA TGG CGA ATT GGG TAC CGG G-3′) and Tom22-tag-R (5′-CCT TTT CTA AAA CCC TCT CTT TTC TTT TAC ATC ATT AAA ACA GGA AAC AGC TAT GAC-3′). The amplified DNA fragments were integrated into the 3′-end of the corresponding WT gene of the haploid strain W303-1A, and his+ transformants were selected. GAL7-TOM22, a yeast strain for expression of Tom22 from the GAL7 promoter, was constructed as follows. A DNA fragment containing the GAL7 promoter was amplified from plasmid pCgHIS3-GAL7 by PCR using primer pairs Tom22-off-F (5′-TCA AAA CGG AAC TAT ATA CCC CAA AAT AAG CAT CAT TCA AAA GCT TGG GTC TTC TGG AGC-3′) and Tom22-off-R (5′-ATT GAA CGA CAT CGT CTT TAA TTT CAG TTA ATT CGA CCA TTT TTG AGG GAA TAT TCA ACT-3′). The amplified DNA fragment was integrated into the chromosome upstream of the TOM22 gene of the WT strain W303-1A and his+ transformants were selected.
Plasmids. Plasmids and primers used in this study are described in Tables S2-S4 . The pTS1 plasmid was constructed as follows. The TOM22-HIS10 gene was amplified from pSU22 (see below) by PCR using primer pairs of Tom22C (5′-CGC GAA TTC ATG GTC GAA TTA ACT GAA-3′) and Tom22E (5′-GCG AAG CTT TTA ATG ATG ATG ATG ATG GTG ATG ATG GTG GTG CCC GGG GGA TCC ATT GGC TGT TGC TGC AGC-3′). The amplified DNA fragment was digested with EcoRI and HindIII, and inserted into the EcoRI/HindIII site between the GAL1 promoter and CMK1 terminator of the CEN-URA3 plasmid, YCpUG578T, to generate pSU22H. A SpeI/XhoI fragment of pSU22H containing the GAL1 promoter, TOM22-HIS10 gene and CMK1 terminator was introduced into the SpeI/XhoI site of the CEN-LEU2 plasmid, pRS315, to generate pTS1. For in vivo photocross-linking, pTS1-X plasmids were constructed as follows. The codon for residue x of Tom22His10 in pTS1 was replaced with the amber codon by Quick-change using a primer pair of Tom22(x)-amber-Fw and Tom22(x)-amber-Rv (Table S3) to generate pTS1-X.
For in vivo and in organello photocross-linking, pTS2-X plasmids were constructed as follows. The TOM22 promoter and terminator were amplified from the yeast genomic DNA by PCR using primer pairs of Tom22P-f (5′-CGG GAT CCC AAA AAG AGC TAA TCA ACT CCT TG-3′) with Tom22P-r (5′-CGG AAT TCG ATG CTT ATT TTG GGG TAT ATA GT-3′) and Tom22T-f (5′-CCC CAA GCT TTG ATG TAA AAG AAA AGA GAG GGT T-3′) with Tom22T-r (5′-CCA TCG ATT GAA ATA TGT ACA AGT TTA TAC AT-3′), respectively. The amplified DNA fragment containing the TOM22 promoter was digested with BamHI and EcoRI, and inserted into the BamHI/EcoRI site of the CEN-URA3 plasmid, YCpUG578T, to generate YCpUG578T-Tom22ownP. The amplified DNA fragment containing the TOM22 terminator was digested with HindIII and ClaI, and inserted into the HindIII/ClaI site of the YCpUG578T-Tom22ownP plasmid to generate YCpUG578T-Tom22ownPT. The EcoRI/HindIII fragment of pTS1-X containing the TOM22-HIS10 gene with the amber codon for position X was introduced into the EcoRI/HindIII site of YCpUG578T-Tom22ownPT to generate pTS2-X.
The pTS3 plasmid was constructed as follows. The TOM22 gene was amplified from the genomic DNA by PCR using a primer pair of Tom22C (5′-CGC GAA TTC ATG GTC GAA TTA ACT GAA-3′) and Tom22B (5′-GCG AAG CTT TTA ATT GGC TGT TGC TGC-3′). The amplified DNA fragment was digested with EcoRI and HindIII, and inserted into the EcoRI/HindIII site of the CEN-URA3 plasmid, YCpUG578T, to generate pSU22. A BamHI/XhoI fragment of pSU22 containing the GAL1 promoter, TOM22 gene, and CMK1 terminator was introduced into the BamHI/XhoI site of the CEN-LEU2 plasmid, pRS315, to generate pTS3. For in vivo photocross-linking, pTS3-X plasmids were constructed as follows. The codon for residue x of Tom22 in pTS3 was replaced with the amber codon by Quickchange using a primer pair of Tom22(x)-amber-Fw and Tom22 (x)-amber-Rv (Table S3 ) to generate pTS3-X.
The pTS4 plasmid was constructed as follows. The TOM20 gene was amplified from the genomic DNA by PCR using a primer pair of Tom20-His10-N (5′-CGC AGA TCT ATG TCC CAG TCG AAC CCT AT-3′) and Tom20-His10-C (5′-CGC AAG CTT TCA ATG ATG ATG ATG ATG GTG ATG ATG GTG GTG GTC ATC GAT ATC GTT AGC TT-3′). The amplified DNA fragment was digested with BglII and HindIII, and inserted into the BglII/HindIII site of the CEN-URA3 plasmid, YCpUG578T, to generate pTS4. For in vivo and in organello photocross-linking, pTS4-X plasmids were constructed as follows. The codon for residue x of Tom20His10 in pTS4 was replaced with the amber codon by Quick-change using Tom20(x)-amber-Fw and Tom20 (x)-amber-Rv (Table S4 ) to generate pTS4-X.
The pTS5 plasmid was constructed as follows. The gene for pb 2 ð167ÞΔ19-DHFR was amplified from pGEM4Z-pb 2 ð167ÞΔ19-DHFR (7) by PCR using a primer pair of pb2(BglII)-N (5′-CCC AGA TCT ATG CTA AAA TAC AAA CCT TT-3′) and DHFR (HindIII)-C (5′-GGG AAG CTT TTA GTC TTT CTC CTC GTA GA-3′). The amplified DNA fragment was digested with BglII and HindIII, and inserted into the BglII/HindIII site of CEN-URA3 plasmid, YCpUG578T, to generate YCpUG578T-pb 2 ð167ÞΔ19-DHFR. A SalI/SacII fragment of YCpUG578T-pb 2 ð167ÞΔ19-DHFR containing the GAL1 promoter, pb 2 ð167ÞΔ19-DHFR gene, and CMK1 terminator gene was introduced into the SalI/SacII site of a 2μ-URA3 plasmid, pYO326, to generate pTS5.
Growth Conditions. Cells were grown in YPD (1% yeast extract, 2% polypeptone, and 2% glucose), SD (0.67% yeast nitrogen base without amino acids and 2% glucose), SCD (0.67% yeast nitrogen base without amino acids, 0.5% casamino acid, and 2% glucose), SGal (0.67% yeast nitrogen base without amino acids and 2% galactose), or SCGal (0.67% yeast nitrogen base without amino acids, 0.5% casamino acid, and 2% galactose) media with appropriate supplements.
In Vivo Photocross-Linking. For overexpression of Tom22-His 10 containing DL-2-amino-3-(p-benzoylphenyl)pentanoic acid (BPA), saturated cultures of TSY1-X and TSY3-X grown in SD (−Trp and −Leu) were transferred to SGal (−Trp, −Leu, and +1 mM BPA) and grown for 16 h. To express Tom22-His 10 containing BPA and suppress expression of endogenous Tom22, a saturated culture of TSY2-X grown in SCGal (−Trp and −Ura) was transferred to SCD (−Trp, −Ura, and +1 mM BPA) and grown for 24 h. For overexpression of Tom20-His 10 containing BPA, a saturated culture of TSY-4 grown in SCD (−Trp and −Ura) was transferred to SCGal (−Trp, −Ura, and +1 mM BPA) and grown for 16 h. BPA (BACHEM) was added to appropriate media from 1 M of stock solution in 1 N NaOH. During cultivations, cells were kept in the dark to prevent BPA from cross-linkng reactions. Yeast cells were harvested and divided into halves. One half was UV-irradiated for 10 min at room temperature at a distance 5 cm from a 365-nm UV lamp (22;000 μW∕cm 2 ; B-100AP; UVP) and the other half was kept on ice. The yeast cells of 6 OD 660 of yeast culture were resuspended in 1 mL of TE buffer (10 mM Tris-HCl, pH 7.5 and 1 mM EDTA) containing 63 μl of 5 N NaOH and 70 mL of β-mercaoptoethanol, and incubated for 4 min on ice. Then proteins were precipitated with 125 μL of 100% (v∕v) TCA and washed with ice-cold acetone.
In Organello Photocross-Linking. Mitochondria were isolated from TSY2-X grown in SCD (−Trp, −Ura, and +1 mM BPA) as described for in vivo photocross-linking. The pGEM4z vector carrying the gene for pSu9-DHFR was used for in vitro transcription with SP6 RNA polymerase. Radiolabeled pSu9-DHFR was synthesized with rabbit reticulocyte lysate in the presence of 35 S-methionine. Isolated mitochondria were incubated with radiolabeled pSu9-DHFR in binding buffer (250 mM sucrose, 10 mM MOPS-KOH (potassium 3-[N-morpholino] propanesulfonate), pH 7.2, 10-150 mM KCl, 5 mM MgCl 2 , 2.5 mM KPi, 5 mM dithiothreitol, 1% (w∕v) BSA, 10 μg∕mL valinomycin) with 2 mM methionine at 4 or 30°C for 10 min, or incubated with the purified rat-pALDH peptide in binding buffer for 10 min on ice. The reaction mixtures were divided into halves, and the one half was UV-irradiated for 10 min at room temperature at a distance 5 cm from a 365-nm UV lamp and the other half kept on ice.
For preparation of the rat-pALDH peptide, a fusion protein consisting of gene10 protein plus one glutamate followed by pALDH was expressed in Escherichia coli cells by using an expression vector pET-17xb (Novagen). The fusion protein was recovered as inclusion bodies, solubilized with 4 M urea, and subjected V8 protease treatment (1∕50 w∕w) to yield pALDH, which was further purified by reversed-phase HPLC. 5  TGGTCGAATTATAGGAAATTAAAGA  TCTTTAATTTCCTATAATTCGACCA  10  AAATTAAAGACTAGGTCGTTCAATT  AATTGAACGACCTAGTCTTTAATTT  15  TCGTTCAATTATAGGAACCACAATT  AATTGTGGTTCCTATAATTGAACGA  20  AACCACAATTTTAGAGAAATCAGGC  GCCTGATTTCTCTAAAATTGTGGTT  25  GAAATCAGGCCTAGGTGGAAGAAAA  TTTTCTTCCACCTAGGCCTGATTTC  30  TGGAAGAAAAGTAGTCTGCAACAAA  TTTGTTGCAGACTACTTTTCTTCCA  35  CTGCAACAAACTAGGACGTTGTCGA  TCGACAACGTCCTAGTTTGTTGCAG  40  ACGTTGTCGATTAGGAAGATGACTC  GAGTCATCTTCCTAATCGACAACGT  41  TTGTCGATGATTAGGATGACTCTGA  TCAGAGTCATCCTAATCATCGACAA  42  TCGATGATGAATAGGACTCTGATAG  CTATCAGAGTCCTATTCATCATCGA  44  ATGAAGATGACTAGGATAGTGATTT  AAATCACTATCCTAGTCATCTTCAT  45  AAGATGACTCTTAGAGTGATTTTGA  TCAAAATCACTCTAAGAGTCATCTT  46 ATGACTCTGATTAGGATTTTGAAGA TCTTCAAAATCCTAATCAGAGTCATX Tom22 (x) amber Fw Tom22 (x) amber Rv   135  ATTTACAAAGTTAGGCTAATAACAT  ATGTTATTAGCCTAACTTTGTAAAT  136  TACAAAGTGATTAGAATAACATATT  AATATGTTATTCTAATCACTTTGTA  137  AAAGTGATGCTTAGAACATATTGGC  GCCAATATGTTCTAAGCATCACTTT  138  GTGATGCTAATTAGATATTGGCCCA  TGGGCCAATATCTAATTAGCATCAC  139  ATGCTAATAACTAGTTGGCCCAAGG  CCTTGGGCCAACTAGTTATTAGCAT  140  CTAATAACATATAGGCCCAAGGTGA  TCACCTTGGGCCTATATGTTATTAG  141  ATAACATATTGTAGCAAGGTGAAAA  TTTTCACCTTGCTACAATATGTTAT  142  ACATATTGGCCTAGGGTGAAAAAGA  TCTTTTTCACCCTAGGCCAATATGT  143  TATTGGCCCAATAGGAAAAAGATGC  GCATCTTTTTCCTATTGGGCCAATA  145  CCCAAGGTGAATAGGATGCTGCAGC  GCTGCAGCATCCTATTCACCTTGGG  146 AAGGTGAAAAATAGGCTGCAGCAAC GTTGCTGCAGCCTATTTTTCACCTT TTGACTATCAATAGAGAAATAGCCC  GGGCTATTTCTCTATTGATAGTCAA  41  CGCAATTCAGGTAGGTGTTGAGACA  TGTCTCAACACCTACCTGAATTGCG  49  AAAGGGCCAAATAGCAGGCCAAGAT  ATCTTGGCCTGCTATTTGGCCCTTT  57  TGGAAGAACAATAGAAAACTCATGC  GCATGAGTTTTCTATTGTTCTTCCA  65  CTAAGGAAGTGTAGCTGCAAAAGGT  ACCTTTTGCAGCTACACTTCCTTAG  73  TTACCGAATTCTAGTCCATGGAATT  AATTCCATGGACTAGAATTCGGTAA  79  TGGAATTAGCCTAGGACCCCATCCC  GGGATGGGGTCCTAGGCTAATTCCA  81  TAGCCAAGGACTAGATCCCTAGTGA  TCACTAGGGATCTAGTCCTTGGCTA  87  CTAGTGATCCCTAGGAAAGAGAAGC  GCTTCTCTTTCCTAGGGATCACTAG  91  CCGAAAGAGAATAGACATTTACCAC  GTGGTAAATGTCTATTCTCTTTCGG  93  GAGAAGCTACATAGACCACCAACGT  ACGTTGGTGGTCTATGTAGCTTCTC  95  CTACATTTACCTAGAACGTAGAAAA  TTTTCTACGTTCTAGGTAAATGTAG  97  TTACCACCAACTAGGAAAATGGTGA  TCACCATTTTCCTAGTTGGTGGTAA  98  CCACCAACGTATAGAATGGTGAAAG  CTTTCACCATTCTATACGTTGGTGG  99  CCAACGTAGAATAGGGTGAAAGATT  AATCTTTCACCCTATTCTACGTTGG  102  AAAATGGTGAATAGTTATCCATGCA  TGCATGGATAACTATTCACCATTTT  105  AAAGATTATCCTAGCAACAAGGTAA  TTACCTTGTTGCTAGGATAATCTTT  108  CCATGCAACAATAGAAGGAACTGGA  TCCAGTTCCTTCTATTGTTGCATGG  111  AAGGTAAGGAATAGGAAGCAGCCTC  GAGGCTGCTTCCTATTCCTTACCTT  112  GTAAGGAACTGTAGGCAGCCTCTAA  TTAGAGGCTGCCTACAGTTCCTTAC  115  TGGAAGCAGCCTAGAAGTTTTATAA  TTATAAAACTTCTAGGCTGCTTCCA  116  AAGCAGCCTCTTAGTTTTATAAAGC  GCTTTATAAAACTAAGAGGCTGCTT  118  CCTCTAAGTTTTAGAAAGCATTGAC  GTCAATGCTTTCTAAAACTTAGAGG  121  TTTATAAAGCATAGACTGTATACCC  GGGTATACAGTCTATGCTTTATAAA  123  AAGCATTGACTTAGTACCCTCAGCC  GGCTGAGGGTACTAAGTCAATGCTT  126  CTGTATACCCTTAGCCAGCCGATTT  AAATCGGCTGGCTAAGGGTATACAG  128  ACCCTCAGCCATAGGATTTATTGGG  CCCAATAAATCCTATGGCTGAGGGT  131  CAGCCGATTTATAGGGAATTTACCA  TGGTAAATTCCCTATAAATCGGCTG  134  TATTGGGAATTTAGCAAAGATCCAT  ATGGATCTTTGCTAAATTCCCAATA  138  ACCAAAGATCCTAGCCTGAAGCCAT  ATGGCTTCAGGCTAGGATCTTTGGT  143  CTGAAGCCATTTAGGAATATATTAT  ATAATATATTCCTAAATGGCTTCAG  147  ACGAATATATTTAGTTAATGATTGC  GCAATCATTAACTAAATATATTCGT  152  TAATGATTGCCTAGTTGCCTCCTGC  GCAGGAGGCAACTAGGCAATCATTA  156  TCTTGCCTCCTTAGAATGTGGCTTC  GAAGCCACATTCTAAGGAGGCAAGA  161  ATGTGGCTTCTTAGGTTAAAGGAGT  ACTCCTTTAACCTAAGAAGCCACAT  166  TTAAAGGAGTTTAGGGAAGCAAGGC  GCCTTGCTTCCCTAAACTCCTTTAA  176  CTGATGCGGTTTAGGAAGCTAACGA  TCGTTAGCTTCCTAAACCGCATCAG 
